Hims & Hers Health

Hims & Hers Health is a direct-to-consumer telehealth company: a consumer answers an intake online, a licensed clinician reviews it, and appropriate treatments or personal-care products arrive by mail, often on a subscription. Founded in 2017, it launched Hims for men's health — the stigmatized, high-intent problems like hair loss and erectile dysfunction that people hesitate to raise with a doctor in person — and added Hers in 2018 for women's health, including birth control, hair, and skincare. From there it widened into weight management, mental health, dermatology, and general wellness. It trades publicly on the New York Stock Exchange under the ticker HIMS, which shapes its behavior: as a public company it lives under quarterly scrutiny, and its growth, subscriber counts, and marketing spend are matters of public record.

What distinguishes Hims & Hers is less the telehealth mechanics — several companies do those — than the scale and loudness of the consumer brand it built on top. It spends heavily on marketing, cultivates a distinctive, approachable brand voice, and treats a category people once whispered about as something to advertise confidently and broadly. The business runs on recurring subscriptions, so its economics turn on acquiring customers efficiently and keeping them, exactly like any subscription brand. For a marketer, Hims & Hers is a textbook direct-to-consumer example (in the plain sense): a company that used a stigmatized, high-intent need as a wedge, then built a wide wellness catalog and an unusually strong brand against the customer relationship it earned.

The closest cousin is Ro, and the pairing is genuinely instructive because the two are so similar. Both are DTC telehealth brands that began in men's sexual health, both expanded into women's health, weight, hair, and skin, and both run on online consultation, mail-order treatment, and subscriptions. They compete directly on most conditions. The differences are in emphasis. Hims & Hers went public early and built an unusually large, consumer-facing brand machine — heavy performance marketing, a recognizable voice, a wide personal-care catalog, and the visibility of a listed company. Ro leaned harder into owning pharmacy and clinical infrastructure in-house, framing itself as a full patient-care operation with its own dispensing engine.

Holding these two side by side clarifies both. If you study Hims & Hers, you are studying marketing scale and brand-building applied to telehealth — a company that made a private category loud and public. If you study Ro, you are studying clinical and pharmacy infrastructure under a strong brand. Both prove the same underlying thesis: win a stigmatized, high-intent health problem online, earn the customer relationship, then expand the catalog against it. Treating them as interchangeable misses the distinct bets — Hims & Hers on brand and marketing reach, Ro on infrastructure — so competitive analysis should hold the shared DTC-telehealth model constant and read each company's different wager against it.

The transferable lessons from Hims & Hers apply to any direct-to-consumer brand, health or not. It shows the power of a clear wedge — a specific, high-intent problem people struggle to solve elsewhere — and of a brand confident enough to talk plainly about something customers found awkward, which itself lowered the barrier to buying. It shows subscription economics in action: because the model is recurring, retention and lifetime value decide whether the heavy acquisition spend pays back, so the brand must keep customers, not just win them. And it shows disciplined catalog expansion, adding categories against an audience that already trusts the brand rather than launching everything at once.

The cautions are the ones that come with marketing a regulated health service loudly. Aggressive advertising in healthcare collides with clinical responsibility, so a telehealth brand that oversells convenience or outcomes risks trust, patient safety, and regulatory attention simultaneously. As a public company, Hims & Hers also faces pressure to grow fast, which can tempt overspending on acquisition or overpromising in messaging. And leaning on stigmatized categories for growth demands respectful, evidence-based communication rather than exploitation. The discipline is to remember that behind the strong brand sits a clinical service, and the two must stay balanced — the marketing that built the company can undermine it if it outruns the medicine.

Hims & Hers Health is a publicly traded direct-to-consumer telehealth and wellness company, founded in 2017, that sells online care and treatments across many conditions, at large marketing scale.

Etymology: source.

Search interest for this term over the last five years:

View interest-over-time on Google Trends →

Areas of marketing where hims & hers health is a core concern: